feedback

Course Director

Ken Fujioka, MD
Ken Fujioka, MD

Scripps Clinic
San Diego, California

Faculty

Louis J. Aronne
Louis J. Aronne, MD, FACP, DABOM

Weill Cornell Medicine
New York, New York

Donna H. Ryan
Donna H. Ryan, MD

Pennington Biomedical Research Center
Baton Rouge, Louisiana

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME / CE
Credit Amount:1.5 Credits
Release Date:2017-Nov-30
Expiration Date:2018-Nov-29
Estimated Time for Completion:90 minutes
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives

In this activity, experts in the management of obesity discuss the management of patients who are overweight/obese through pharmacologic and nonpharmacologic treatment.

Upon completion of this activity, participants will be able to:

  • Employ a collaborative decision-making approach to weight loss management, including setting realistic and effective treatment goals, based on an understanding of the underlying cause of patient’s obesity and barriers to attaining and maintaining weight loss
  • Provide guidance on appropriate selection of adjunctive pharmacotherapies, according to mechanism of action and relevant clinical data, to manage obesity and related complications
  • Develop appropriate management plans combining behavioral interventions, lifestyle modifications, and anti-obesity pharmacotherapy based on individual patient- and disease-related characteristics to achieve improved outcomes

Target Audience

This activity has been designed to meet the educational needs of primary care physicians, endocrinologists, bariatricians, nurses and other clinicians involved in the management of patients who are overweight/obese.

Nursing Education Purpose Statement

The purpose of this activity is to improve knowledge and competence of nurses concerning the treatment of overweight/obese patients.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME/CE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: November 30, 2017 - November 29, 2018
Time to Complete: 90 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE activity during the past 12 months.

Course Director and Moderator

Ken Fujioka, MD
Director of Nutrition and Metabolic Research
Scripps Clinic, Department of Endocrinology
San Diego, California

Ken Fujioka, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Ambra BioScience; Boehringer Ingelheim; Eisai Inc.; Gelesis; KVK Tech, Inc.; Novo Nordisk; Orexigen Therapeutics, Inc.; Shire; and Zafgen.
Speakers Bureau participant with AbbVie Inc.; Novo Nordisk; Orexigen Therapeutics, Inc.; and Shire.
Ken Fujioka, MD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: Combination anti-obesity therapy.

Faculty

Louis J. Aronne, MD, FACP, DABOM
Weill Cornell Medicine
Chairman, American Board of Obesity Medicine
New York, New York

Louis J. Aronne, MD, FACP, DABOM, has a financial interest/relationship or affiliation in the form of:
Consultant for Eisai Co., Ltd; Gelesis; GI Dynamics; Jamieson Laboratories; Janssen Pharmaceuticals, Inc.; Novo Nordisk A/S; Pfizer Inc.; Real Appeal, Inc.; and UnitedHealth Group.
Grant/Research Support from Aspire Bariatrics; AstraZeneca; and Eisai Co., Ltd.
Advisory Board for BMIQ; Gelesis; Jamieson Laboratories; MYOS RENS Technology Inc.; and Zafgen.
Louis J. Aronne, MD, FACP, DABOM, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: Combination anti-obesity therapy.

Donna H. Ryan, MD
Professor Emerita and Executive Director
Pennington Biomedical Research Center
Baton Rouge, Louisiana

Donna H. Ryan, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Eisai Inc.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novo Nordisk A/S; Orexigen Therapeutics, Inc.; and Real Appeal, Inc.
Speakers Bureau participant with Eisai Inc.; Novo Nordisk A/S; and Orexigen Therapeutics, Inc.
Stock Shareholder in Gila Therapeutics, Inc. and Scientific Intake.
Other Financial or Material Support from BaroNova, Inc. in the form of Data and Safety Monitoring Board (DSMB).
Donna H. Ryan, MD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: Combination anti-obesity therapy.

CME Reviewer

Matthew A. Goodman, MD
Attending Physician Internal Medicine
Abington Jefferson Health

Matthew A. Goodman, MD, has no financial interests/relationships or affiliations in relation to this activity.

Nurse Reviewer

Pamela Ash, RN, MSN, CBCN
Mary Babb Randolph Cancer Center Clinic
West Virginia University
Morgantown, West Virginia

Pamela Ash, RN, MSN, CBCN, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Chris Washburn, PhD
PVI, PeerView Institute for Medical Education

Chris Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hour(s).

Providership

This CME/CE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an educational grant from Novo Nordisk, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME/CE Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.


Copyright © 2000-2017, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.